ALPS Advisors’s Biomea Fusion BMEA Stock Holding History

ALPS Advisors’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,188	Closed	-$377K	–	971
2024 Q1	$377K	Sell	25,188 -5,211	-17%	-$85.8K	﹤0.01%	680
2023 Q4	$441K	Buy	+30,399	New	+$369K	﹤0.01%	626

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ALPS Advisors's BMEA Position: Q2 2024 in Review

ALPS Advisors sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 25,188 shares — an estimated $377K sold.

ALPS Advisors first reported a position in BMEA in Q4 2023 and held it in 2 quarters. The position peaked at $441K in Q4 2023. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

ALPS Advisors reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
ALPS Advisors sold 25,188 Biomea Fusion shares in Q2 2024, an estimated $377K.
ALPS Advisors first reported a position in Biomea Fusion in Q4 2023 and held it in 2 quarters.
ALPS Advisors's Biomea Fusion position peaked at $441K in Q4 2023.
107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.